Actively Recruiting
An Ethical Approach to Detecting Covert Consciousness: Data-Driven Neuroethics for Consciousness Detection
Led by Massachusetts General Hospital · Updated on 2025-09-11
70
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research focuses on patients with disorders of consciousness (DoC), such as coma, vegetative state, or minimally conscious state, where traditional bedside exams may misdiagnose consciousness in up to 40% of cases. The study aims to explore the ethical issues around new neurotechnologies like functional MRI and EEG that help detect hidden consciousness and predict recovery after brain injuries. It seeks to understand the perspectives of clinicians, researchers, patients, and caregivers to support responsible use of these tools. Participants include patients and their family members or caregivers involved in research using these neurotechnologies, as well as clinicians, researchers, and community leaders engaged in brain injury care and policy. The study uses surveys and semi-structured interviews to gather information about attitudes, expectations, and concerns related to sharing uncertain diagnostic data from advanced neurotechnologies. These methods will be conducted over an average of one year. During the study, participants will complete questionnaires and interviews to share their views on ethical and practical aspects of using neurotechnologies in diagnosing and prognosing consciousness. The primary outcome involves analyzing these survey and interview responses throughout the study. The research is observational and includes ongoing monitoring of participants' feedback without administering treatments, with participation lasting about one year on average.
CONDITIONS
Brief Title
An Ethical Approach to Detecting Covert Consciousness
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have participated or are participating in neurotechnology research for diagnosing or predicting disorders of consciousness at Mass General Brigham
- Patients who can understand and respond to questions in English
- Patients able to give informed consent
- Patients undergoing MRI or EEG for clinical detection of consciousness or prognosis
- Family members or surrogate caregivers of such patients who can understand and respond in English and provide informed consent
- Researchers involved in designing or testing neurotechnologies on patients with disorders of consciousness
- Clinicians caring for patients in coma, vegetative state, or minimally conscious state
- Selected leaders and advisors from brain injury organizations and policy-makers involved in decisions affecting patients with disorders of consciousness
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Varies according to clinical evaluations
Participants undergo advanced neurotechnologies such as MRI or EEG to detect consciousness and predict recovery.
1 to 2 visits depending on procedures
Duration - Up to 1 year
Participants including patients, caregivers, clinicians, and researchers complete surveys and semi-structured interviews to share preferences, expectations, and concerns about data-sharing of diagnostic results.
Periodic assessments throughout study duration
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
M
Michael Young, MD
B
Brian Edlow, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here